1 – 18 of 18
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Increases in bioactive IGF do not parallel increases in total IGF-I during growth hormone treatment of children born SGA
(
- Contribution to journal › Article
-
Mark
Randomized Control Trial of Postnatal rhIGF-1/rhIGFBP-3 Replacement in Preterm Infants : Post-hoc Analysis of Its Effect on Brain Injury
(
- Contribution to journal › Article
- 2019
-
Mark
Serum kidney injury molecule 1 and β2-microglobulin perform as well as larger biomarker panels for prediction of rapid decline in renal function in type 2 diabetes
(
- Contribution to journal › Article
-
Mark
rhIGF-1/rhIGFBP-3 in Preterm Infants : A Phase 2 Randomized Controlled Trial
(
- Contribution to journal › Article
- 2017
-
Mark
The exon3-deleted growth hormone receptor gene polymorphism (d3-GHR) is associated with insulin and spontaneous growth in short SGA children (NESGAS)
(
- Contribution to journal › Article
-
Mark
The genetic landscape of renal complications in type 1 diabetes
(
- Contribution to journal › Article
- 2016
-
Mark
Insulin-like growth factor 1 has multisystem effects on fetal and preterm infant development.
(
- Contribution to journal › Scientific review
-
Mark
Developmental programming : State-of-the-science and future directions: Summary from a Pennington Biomedical symposium
(
- Contribution to journal › Scientific review
-
Mark
GH Safety Workshop Position Paper: a critical appraisal of recombinant human growth hormone therapy in children and adults.
(
- Contribution to journal › Article
- 2015
-
Mark
Adiposity in children born small for gestational age is associated with β-cell function, genetic variants for insulin resistance and response to growth hormone treatment.
(
- Contribution to journal › Article
-
Mark
Genetic Markers of Insulin Sensitivity and Insulin Secretion Are Associated With Spontaneous Postnatal Growth and Response to Growth Hormone Treatment in Short SGA Children: the North European SGA Study (NESGAS)
(
- Contribution to journal › Article
-
Mark
Biomarkers of rapid chronic kidney disease progression in type 2 diabetes.
(
- Contribution to journal › Article
- 2014
-
Mark
A randomised controlled trial evaluating IGF-I titration in contrast to current GH dosing strategies in children born Small for Gestational Age (NESGAS).
(
- Contribution to journal › Article
-
Mark
Genome-wide association study of urinary albumin excretion rate in patients with type 1 diabetes
(
- Contribution to journal › Article
- 2013
-
Mark
Baseline IGF-I Levels Determine Insulin Secretion and Insulin Sensitivity during the First Year on Growth Hormone Therapy in Children Born Small for Gestational Age. Results from a North European Multicentre Study (NESGAS)
(
- Contribution to journal › Article
- 2009
-
Mark
Insulin-like growth factor-I, d3-GHR gene polymorphism, prematurity and height at start as determinants of one year growth response during high dose GH; preliminary results from the NESGA study (NESGAS)
(
- Contribution to journal › Published meeting abstract
-
Mark
Phenotypic characteristics of short children born SGA. Baseline data from the North European small for gestational age study (NESGAS)
(
- Contribution to journal › Published meeting abstract
-
Mark
Changes in body composition as assessed by DXA scan after one year of high dose growth hormone treatment in children born SGA. Results from the NESGAS group
(
- Contribution to journal › Published meeting abstract